Trial
NCT03726996
Desipramine in Infantile Neuroaxonal Dystrophy (INAD).
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Duke University
Collaborators
—
Condition
Infantile Neuroaxonal Dystrophy
Intervention
Desipramine
Why stopped
Funding exhausted
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-10-14